Catalent | Les Charges D'Exploitation



Operating Expenses Changement Date
Agilent USD 1.37B 63M 2025-04
AstraZeneca USD 9.91B 2.94B 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Bruker USD 769.6M 145.9M 2025-03
Centene USD 45.09B 4.46B 2025-03
Charles River Laboratories USD 909.5M 260.74M 2025-03
Cigna USD 63.49B 144M 2025-03
Danaher USD 4.46B 655M 2025-03
Dentsply International USD 816M 598M 2025-03
Elevance Health USD 46.09B 1.6B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Hologic USD 1.01B 220.3M 2025-03
Humana USD 30.1B 342M 2025-03
Illumina USD 910M 19M 2025-03
Intuitive Surgical USD 1.68B 3.3M 2025-03
IQVIA Holdings USD 3.34B 5M 2025-03
J&J USD 8.26B 10.37B 2025-03
Laboratory Of America USD 3.01B 100.2M 2025-03
Lonza CHF 3.09B 564M 2024-12
McKesson USD 89.23B 4.84B 2025-03
Merck EUR 4.27B 51M 2025-03
Merck USD 9.66B 1.67B 2025-03
Mettler Toledo International USD 681.8M 48.78M 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Quest Diagnostics USD 2.31B 46M 2025-03
Repligen USD 162.59M 41.45M 2025-03
Revvity USD 592.53M 18.09M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Thermo Fisher Scientific USD 8.65B 731M 2025-03
UnitedHealth USD 100.47B 7.46B 2025-03
Waters USD 509.96M 70.49M 2025-03
West Pharmaceutical Services USD 591M 1.8M 2025-03



Catalent Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.